Why Class IV Power Matters
Lower-powered Class III ("cold") lasers deliver the same type of light, but at such low intensity that reaching deep tissues requires very long treatment times — often making clinical application impractical. Class IV lasers, with outputs from 500 mW up to 30,000 mW (30 W) per diode, deliver therapeutic energy doses to deep targets in 2–10 minutes. This is not merely a time convenience: adequate energy delivery is essential for a therapeutic cellular response. The Arndt-Schulz Law — validated across photobiomodulation research — confirms that a minimum threshold of light energy must reach the target tissue for a biological effect to occur.
The Quad-Wave Advantage
The VLASER | 47W ELITE QUAD WAVE uniquely delivers four therapeutic wavelengths simultaneously, blended through a fiber optic delivery cable, providing comprehensive multi-depth tissue coverage in a single treatment pass:
Wavelength
Primary Mechanism
Target Tissue/Use
635 nm(Red)
Melanin absorption, collagen stimulation
Superficial: skin, scars, wounds, burns
810 nm(NIR)
Hemoglobin oxygenation, mitochondrial CcO activation
Mid-depth: muscles, tendons, lymphatics
980 nm(NIR)
Thermo/mechanical receptor activation
Pain receptors, circulation, muscle relaxation
1064 nm(NIR)
Deepest tissue penetration, minimal melanin absorption
Deep joints, ligaments, discs, bone
The biological "optical window" — approximately 600 nm to 1100 nm — is where tissue absorption by water and hemoglobin is at its lowest, allowing photons to travel deeper into tissue. By delivering all four wavelengths simultaneously through a fiber optic handpiece, the VLASER | QUAD WAVE lasers cover this entire therapeutic window in a single treatment, addressing superficial, mid-depth, and deep structures concurrently — a capability not achievable with single- or dual-wavelength systems.
The system operates at a combined maximum output of up to 32W or 47 watts, with protocols ranging from 3 W to 33 W delivering photon density sufficient to produce measurable mitochondrial effects in deep-seated cells at clinically relevant treatment depths.
